Clinical Trials · NCT07430059
Safety, Tolerability and Pharmacokinetics of a Subcutaneous Semaglutide Implant
- Phase
- Phase 1
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Vivani Medical, Inc
- Enrollment
- 20
- Start date
- Jul 2026
- Locations
- See registry
- Primary endpoint
- Area under the plasma concentration-time curve (AUC)